Cargando…
Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer
INTRODUCTION: Buruli ulcer (BU) is the third most frequent mycobacterial disease in immunocompetent persons after tuberculosis and leprosy. During the last decade, eight weeks of antimicrobial treatment has become the standard of care. This treatment may be accompanied by transient clinical deterior...
Autores principales: | Barogui, Yves Thierry, Klis, Sandor-Adrian, Johnson, Roch Christian, Phillips, Richard O., van der Veer, Eveline, van Diemen, Cleo, van der Werf, Tjip S., Stienstra, Ymkje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838240/ https://www.ncbi.nlm.nih.gov/pubmed/27097163 http://dx.doi.org/10.1371/journal.pntd.0004594 |
Ejemplares similares
-
Towards Rational Use of Antibiotics for Suspected Secondary Infections in Buruli Ulcer Patients
por: Barogui, Yves T., et al.
Publicado: (2013) -
Wound Care in Buruli Ulcer Disease in Ghana and Benin
por: Velding, Kristien, et al.
Publicado: (2014) -
Long Term Streptomycin Toxicity in the Treatment of Buruli Ulcer: Follow-up of Participants in the BURULICO Drug Trial
por: Klis, Sandor, et al.
Publicado: (2014) -
Former Buruli Ulcer Patients’ Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management
por: Velink, Anita, et al.
Publicado: (2016) -
Assessment and Treatment of Pain during Treatment of Buruli Ulcer
por: de Zeeuw, Janine, et al.
Publicado: (2015)